Skip to main content
OpenTrials

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,526 public trials 2,840 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Recruiting

A Study to Assess Adverse Events and How Intravenous (IV) Pivekimab Sunirine Moves Through the Body in Pediatric Participants With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT07306832

Conditions
Acute Myeloid Leukemia, Disease Attributes, Hematologic Diseases, +9 more
Locations
  • Lucile Packard Children's Hospital /ID# 276015 Palo Alto, California, United States
  • New York Medical College /ID# 275597 Valhalla, New York, United States
  • Tristar Centennial Medical Center /ID# 275831 Nashville, Tennessee, United States
  • Perth Children'S Hospital /ID# 275673 Perth, Western Australia, Australia
View all 13 locations
View Trial Details
Recruiting

A Study of Ruxolitinib and Duvelisib in People With Lymphoma

NCT05010005

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +22 more
Locations
  • University of Miami (Data Collection Only) Miami, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
View Trial Details
Recruiting

Rituximab (Rtx) + Tafasitamab in Combination With Allogeneic NK Cells for Treatment of Relapsed/Refractory (r/r) B-cell Non-Hodgkin Lymphoma (NHL)

NCT07225439

Conditions
B-cell Non Hodgkin Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +30 more
Locations
  • Case Comprehensive Cancer Center, University Hospitals Seidman Cancer Center Cleveland, Ohio, United States
  • Case Comprehensive Cancer Center, Cleveland Clinic Foundation Taussig Cancer Institute Cleveland, Ohio, United States
View Trial Details
Recruiting

Observational Study of Acalabrutinib in Patients With Chronic Lymphocytic Leukaemia in the United Kingdom

NCT05557695

Conditions
Chronic Lymphocytic Leukemia, CLL, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Research Site Aylesbury, United Kingdom
  • Research Site Bath, United Kingdom
  • Research Site Birmingham, United Kingdom
  • Research Site Bournemouth, United Kingdom
View all 29 locations
View Trial Details
Recruiting

A Study of Gammagard Liquid (Immune Globulin Infusion, 10%) to Prevent Infections in Adults With Multiple Myeloma

NCT06980480

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • Infirmary Health - Diagnostic & Medical Clinic (DMC) Mobile, Alabama, United States
  • Chao Family Comprehensive Cancer Center UCI Orange, California, United States
  • University of Kansas Westwood, Kansas, United States
  • University of Maryland | Greenebaum Cancer Center Baltimore, Maryland, United States
View all 56 locations
View Trial Details
Recruiting

A Study to Assess the Tolerability of Ianalumab (VAY736) With Investigator's Choice Thrombopoietin Receptor Agonist (IC TPO-RA) in Patients With Primary Immune Thrombocytopenia (ITP)

NCT07421167

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +18 more
Locations
  • Stamford Hospital Stamford, Connecticut, United States
  • Baptist MD Anderson Cancer Center Jacksonville, Florida, United States
  • DH Cancer Research Center LLC Margate, Florida, United States
  • Hope And Healing Care Hinsdale, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)

NCT05582993

Conditions
Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Blood Platelet Disorders, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Bleeding and Clotting Disorders Institute Peoria, Illinois, United States
  • Riley Hospital for Children Indiana University Health Indianapolis, Indiana, United States
  • University of Iowa Hospitals & Clinics PARENT Iowa City, Iowa, United States
View all 23 locations
View Trial Details

Related conditions